Steven B. Ruchefsky, Director at Kite Pharma, Inc. (KITE), sold 20,000 shares at $89.48 ($1.8M) on 2017-06-14, disclosed to the SEC on 2017-06-16.
Open-market sale of $1.8M KITE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |